Lumentum's Nasdaq-100 Debut Marred by 8% Plunge as Production Limits Challenge AI Demand

Lumentum shares fell 8% on profit-taking after a 1,000% rally, but the shift to 1.6T transceivers and vertical integration underpin robust fundamentals despite capacity constraints.

Lumentum picked a curious day to join the Nasdaq-100. The photonics specialist saw its shares slide more than 8% on Monday, sliding to roughly €760, even as index funds began positioning for the new weight. It capped a week that had already seen the stock retreat from its 52-week high of €894 to €802.40, as investors took money off the table after a breathtaking rally — nearly 1,000% over the past twelve months and more than 130% year-to-date.

The selling was broad within the optical technology sector. Applied Optoelectronics and Coherent also fell, reflecting a broader cooldown after weeks of outsized gains. For Lumentum, the pullback has carved out a 15% gap from its peak, raising the question of whether the stock's valuation had simply run ahead of near-term realities. The 30-day volatility reading of 91.06% leaves no doubt that this is a high-octane name.

Yet beneath the profit-taking, the fundamental case remains intact — and arguably strengthening. Lumentum is riding a seismic shift in data center architecture as operators move from 800G to 1.6T transceivers. The company plans to begin high-volume shipments of these next-generation components in the current quarter, and it expects its own internal continuous-wave lasers to supply roughly 20% of the initial volumes. That vertical integration should bolster margins, which the company guided to 35-36% operating margin on fourth-quarter revenue of $960 million to $1.01 billion.

Management has also been reshaping the customer base. CEO Michael Hurlston, speaking at a J.P. Morgan conference, outlined a deliberate pivot away from cyclical telecom clients like AT&T and Verizon toward hyperscale cloud operators. The strategy aims to smooth out demand volatility, and early results are visible: third-quarter fiscal revenue surged 90% year-over-year, while the balance sheet holds $3.17 billion in cash and short-term investments to fund expansion.

The bottleneck, however, is on the factory floor. Lumentum's order book now stretches into 2028, but production capacity remains the binding constraint. Shipments are lagging demand for several product lines, especially optical circuit switches and high-power lasers. To ease the squeeze, the company is converting a facility in Greensboro, North Carolina into a 240,000-square-foot plant dedicated to indium phosphide lasers, a technology where Lumentum already commands over 50% market share. The catch: the Greensboro ramp isn't expected to contribute meaningful output until mid-2028, meaning existing capacity will remain stretched for years.

That supply-demand tension has not stopped analysts from raising their targets. Following the Nasdaq-100 upgrade, several firms boosted price objectives, with JPMorgan and Craig Hallum setting ranges of $1,130 to $1,150, and some forecasts reaching as high as $1,300. Zacks Research upgraded the stock to "Strong Buy." Meanwhile, hedge fund manager Leopold Aschenbrenner's Situational Awareness sold its stakes in both Lumentum and Coherent in the first quarter, adding to market chatter about whether the current valuation can be sustained until production catches up with orders.

For now, the technical picture offers a mixed signal: the relative strength index sits at 57.7, suggesting momentum rather than overheating. The real test will be how quickly Lumentum can translate its immense order backlog into shipments — and whether the production ramp in Greensboro and Thailand arrives fast enough to keep the AI-driven story alive without constant margin pressure. Monday's selloff may be a temporary adjustment, but the structural challenge of turning demand into deliveries remains the defining narrative.